ArticleCancer immunology, immunotherapy : CII2021

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

R Kleef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.